1 Department of Respiratory Medicine, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands [email protected].
2 National Jewish Health, Denver, CO, USA.
3 Clinica di Malattie dell'Apparato Respiratorio, Dipartimento di Scienze Cardio-Toraco-Vascolari e Sanità Pubblica, Università degli Studi di Padova, Padova, Italy.
4 McMaster University and St. Joseph's Healthcare, Hamilton, ON, Canada.
5 Mainz Center for Pulmonary Medicine, Department of Pneumology, ZfT, Mainz University Medical Center and Pulmonary, Critical Care and Sleep Medicine, Marienhaus Clinic Mainz, Mainz, Germany.
6 Department of Pulmonology, Hôpital Avicenne, APHP, Bobigny, France.
Among patients with progressive pulmonary fibrosis, worse dyspnoea at baseline and a worsening of dyspnoea over 24 weeks were associated with an increased risk of disease progressionhttps://bit.ly/3APvQL7